Examination of Left Atrial Fibrosis Using MRI

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01233674
First received: November 2, 2010
Last updated: January 4, 2016
Last verified: January 2016
  Purpose
This study evaluates images obtained from a standard clinical cardiac MRI for evidence of fibrosis.

Condition
Fibrosis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Examination of Left Atrial Fibrosis Using MRI

Further study details as provided by University of Pittsburgh:

Enrollment: 0
Study Start Date: March 2011
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
patients referred for standard of care MRI

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients referred for standard of care MRI
Criteria

Inclusion Criteria:

  • 18+ years of age
  • being scheduled for a standard of care MRI

Exclusion Criteria:

- patient unable to provide informed consent

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01233674

Locations
United States, Pennsylvania
UPMC CVI
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
  More Information

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT01233674     History of Changes
Other Study ID Numbers: 08120067 
Study First Received: November 2, 2010
Last Updated: January 4, 2016
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Fibrosis
Pathologic Processes

ClinicalTrials.gov processed this record on July 27, 2016